Home » Glaxo Gets Boost From Merck Drug Deal
Glaxo Gets Boost From Merck Drug Deal
GlaxoSmithKline boosted its over-the-counter medicines business on Monday by signing a deal to sell a non-prescription version of Merck & Co.’s cholesterol-lowering drug Mevacor.
Yahoo! News
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May